Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Aker BioMarine ASA's interest expense for the
six
months ended in Jun. 2026 was € -11.6 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was €-19.9 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Aker BioMarine ASA Interest Expense Historical Data
* Premium members only.
The historical data trend for Aker BioMarine ASA's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-19.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aker BioMarine ASA (FRA:1PG) has a Interest Expense of €-19.9 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Aker BioMarine ASA and its competitors.
Is Aker BioMarine ASA's Interest Expense too high?
Aker BioMarine ASA's current Interest Expense is €-19.9 Mil. Overall, Aker BioMarine ASA has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aker BioMarine ASA's Interest Expense compare to KHC and GIS?
Aker BioMarine ASA's Interest Expense of €-19.9 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Consumer Packaged Goods company?
A good Interest Expense depends on the Consumer Packaged Goods industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Aker BioMarine ASA and its competitors. Aker BioMarine ASA's current Interest Expense is €-19.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aker BioMarine ASA stock overvalued right now?
Based on GuruFocus' analysis, Aker BioMarine ASA (FRA:1PG) is currently considered Significantly Overvalued. The stock's GF Value™ is €6.45, compared to a current price of €9.89 — trading 53.3% above its estimated fair value. The current Interest Expense is €-19.9 Mil. Aker BioMarine ASA's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Aker BioMarine ASA (FRA:1PG), the current Interest Expense is €-19.9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aker BioMarine ASA (FRA:1PG) Overvalued in 2026?
Based on GuruFocus' analysis, Aker BioMarine ASA stock appears to be overvalued.
The current stock price of €9.89 is trading 53.3% above its estimated GF Value™ of €6.45.
GuruFocus considers Aker BioMarine ASA to be Significantly Overvalued.
Key valuation signals for FRA:1PG:
Interest Expense: €-19.9 Mil
GF Value™: €6.45 vs. price of €9.89 (53.3% above fair value)
No single metric tells the full story. See the FRA:1PG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
63GF Score
Get the complete analysis for FRA:1PG
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1PG has been successfully added to your 
